Cleared Traditional

K223217 - Zynex Monitoring System, Model CM-1600 (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223217 · Zynex Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
242d
Days
Class 2
Risk

K223217 is an FDA 510(k) clearance for the Zynex Monitoring System, Model CM-1600. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Zynex Medical, Inc. (Englewood, US). The FDA issued a Cleared decision on June 16, 2023 after a review of 242 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Zynex Medical, Inc. devices

Submission Details

510(k) Number K223217 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 2022
Decision Date June 16, 2023
Days to Decision 242 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 125d · This submission: 242d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 113
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K223217.
BCM2-Body Composition Monitor
K250634 · Fresenius Medical Care Renal Therapies Group, LLC · Nov 2025
Re:Balans
K243727 · Mode Sensors AS · Oct 2025
Edema Guard Monitor (EGM) CardioSet-001
K250922 · Cardioset Medical , Ltd. · Sep 2025
SOZO Pro
K232089 · ImpediMed Limited · Oct 2023
Bodyport Cardiac Scale
K211585 · Bodyport, Inc. · Jul 2022
SOZO
K203473 · ImpediMed Limited · Apr 2021